Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.5440
-0.0261 (-4.58%)
At close: Apr 1, 2025, 4:00 PM
0.5397
-0.0044 (-0.80%)
After-hours: Apr 1, 2025, 4:23 PM EDT

Tenaya Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-111.13-124.08-123.67-72.72-38.4
Upgrade
Depreciation & Amortization
8.478.696.472.962.48
Upgrade
Loss (Gain) From Sale of Assets
----0.03
Upgrade
Loss (Gain) From Sale of Investments
-0.180.32-0.310.13-
Upgrade
Stock-Based Compensation
16.515.3111.472.950.74
Upgrade
Other Operating Activities
3.773.352.461.13-0.08
Upgrade
Change in Accounts Payable
-0.58-3.281.668.60.14
Upgrade
Change in Other Net Operating Assets
-7.35-2.37-2.51-3.86-0.38
Upgrade
Operating Cash Flow
-90.5-102.07-104.42-60.81-35.45
Upgrade
Capital Expenditures
-1.03-1.24-20.63-25.12-9.76
Upgrade
Investment in Securities
2.1449.98104.27-213.442.75
Upgrade
Other Investing Activities
0.02-0.030.01--
Upgrade
Investing Cash Flow
1.1348.7283.65-238.56-7.01
Upgrade
Issuance of Common Stock
47.754.5577.771890.03
Upgrade
Repurchase of Common Stock
----0.01-0
Upgrade
Other Financing Activities
--0.5---
Upgrade
Financing Cash Flow
47.754.0577.77208.97147.27
Upgrade
Net Cash Flow
-41.62-49.3157-90.41104.81
Upgrade
Free Cash Flow
-91.53-103.31-125.05-85.93-45.21
Upgrade
Free Cash Flow Per Share
-1.08-1.40-2.79-4.85-46.51
Upgrade
Levered Free Cash Flow
-52.73-60.78-83.92-52.6-30.25
Upgrade
Unlevered Free Cash Flow
-52.73-60.78-83.92-52.6-30.25
Upgrade
Change in Net Working Capital
4.211.542.71-12.11-0.61
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q